COVID-19 and Big Pharma: Tracking the Impact

The COVID-19 pandemic has harmed people and organizations around the world. For the pharmaceutical industry, however, it has been a more contradictory experience. On the one hand, the pandemic has interrupted supply chains, diminished contact with customers, and threatened stronger government regulation. On the other hand, the virus has created new opportunities for windfall profits, Continue reading COVID-19 and Big Pharma: Tracking the Impact